Via Therapeutics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Via Therapeutics
John Koleng
President/CSO
About Via Therapeutics
Your Direct Route to Formulation Success Via is a dedicated research and development partner specializing in advanced drug delivery systems. We bridge the gap between concept and clinic, turning promising molecules into effective therapies for patients. Our Core Areas of Expertise: 👃 Nasal & Inhaled Delivery: Mastering respiratory routes for systemic and local treatments. 🧴 Topical Systems: Designing sophisticated creams, gels, and patches for targeted application. 💉 Long-Acting Injectables (LAI): Developing innovative solutions to improve patient compliance and therapeutic outcomes. 🧬 Molecule Agnostic: Proven success with both small molecules and large biologics across all our platforms. Facing a formulation roadblock? Let's discuss how Via can accelerate your program's path to success.
Via Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Via Therapeutics has never raised funding before.
Zimbabwe
Australia
Frequently asked questions
4.8
40,000 users
